HC Wainwright Issues Optimistic Outlook for SGMO Earnings
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Analysts at HC Wainwright upped their Q1 2025 earnings per share estimates for shares of Sangamo Therapeutics in a research report issued on Monday, April 7th. HC Wainwright analyst P. Trucchio now forecasts that the biopharmaceutical company will earn ($0.04) per share for the quarter, up from […]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Analysts at HC Wainwright upped their Q1 2025 earnings per share estimates for shares of Sangamo Therapeutics in a research report issued on Monday, April 7th. HC Wainwright analyst P. Trucchio now forecasts that the biopharmaceutical company will earn ($0.04) per share for the quarter, up from […]